BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liszka Ł, Zielińska-Pająk E, Pająk J, Gołka D, Starzewski J, Lorenc Z. Usefulness of two independent histopathological classifications of tumor regression in patients with rectal cancer submitted to hyperfractionated pre-operative radiotherapy. World J Gastroenterol 2007; 13(4): 515-524 [DOI: 10.3748/wjg.v13.i4.515]
URL: https://www.wjgnet.com/1007-9327/full/v13/i4/515.htm
Number Citing Articles
1
Rob Glynne Jones, David Tan. How can we determine the best neoadjuvant chemoradiotherapy regimen for rectal cancer?Colorectal Cancer 2015; 4(1): 37 doi: 10.2217/crc.15.3
2
Hiroshi Doi, Naohito Beppu, Soichi Odawara, Masao Tanooka, Yasuhiro Takada, Yasue Niwa, Masayuki Fujiwara, Fumihiko Kimura, Hidenori Yanagi, Naoki Yamanaka, Norihiko Kamikonya, Shozo Hirota. Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combined with S-1 for locally advanced rectal cancerJournal of Radiation Research 2013; 54(6): 1118 doi: 10.1093/jrr/rrt058